Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Promacta
Promacta
Novartis' blood disorder drug gets FDA approval for expanded use
Reuters
Mon, 11/19/18 - 11:39 pm
Novartis
Promacta
FDA
severe aplastic anemia
FDA Grants Expanded Use of Promacta for Novartis
Yahoo/24-7 Wall St
Tue, 08/25/15 - 08:30 am
FDA
Novartis
Promacta
chronic immune thrombocytopenia
ITP
Glaxo's Promacta Holds Promise
Yahoo/Zacks.com
Tue, 06/17/14 - 06:50 pm
GSK
Promacta
chronic immune thrombocytopenic purpura
Ligand Promacta data should support approval, says Roth Capital
Yahoo/The Fly on the Wall
Mon, 06/16/14 - 10:04 am
Ligand Pharmaceuticals
GSK
Promacta
thrombocytopenia
Ligand says partner GSK submits application for Promacta
Yahoo/Fly on the Wall
Fri, 02/28/14 - 11:48 am
Ligand Pharmaceuticals
GSK
Promacta
GlaxoSmithKline Wins Another FDA ‘Breakthrough’ Designation
Wall St Cheat Sheet
Mon, 02/3/14 - 03:56 pm
GSK
FDA
breakthrough therapies
severe aplastic anemia
Promacta
Revolade
FDA Approval Victory a Yawner?
Motley Fool
Tue, 11/20/12 - 11:24 am
FDA
GSK
Ligand
Promacta
hepatitis C
GlaxoSmithKline announces priority review for Promacta SNDA
The Fly on the Wall
Wed, 07/25/12 - 09:24 am
Promacta
GSK
Ligand trades higher on study of Promacta drug
Yahoo/AP
Tue, 07/26/11 - 01:54 pm
Promacta
Ligand
GSK
hepatitis C
FDA Grants Full Approval for PROMACTA® (eltrombopag) for Treatment of Rare Blood Disorder
Yahoo/PR NewsWire
Sat, 02/26/11 - 10:12 am
Promacta
chronic immune thrombocytopenic purpura
Study of Glaxo platelet drug halted due to clots
Reuters
Thu, 05/13/10 - 09:10 am
GSK
clinical trials
liver disease
Promacta
Ligand Pharmaceuticals, GlaxoSmithKline blood disorder drug moves closer to European approval
Yahoo/AP
Fri, 12/18/09 - 10:34 am
GSK
Ligand
Europe
Promacta
Revolade
GSK Takes Dow Jones to Task - on Its Blog
BNET Pharma
Wed, 11/18/09 - 10:19 am
GSK
Dow Jones
Teva Pharmaceuticals
Promacta